ZIDOVIR
100 MG · capsule · box 100 capsules
ZIDOVUDINEReference dated : 2026-10-01. Confirm price and availability with a pharmacist.
Public price
226,00 MAD
What is this medicine?
French reference leaflet: RETROVIR 100 mg, gélule. Confirm indications in Morocco with a pharmacist.
Pharmacotherapeutic class: nucleoside analogue - ATC code: J05A F01 Retrovir is indicated for the treatment of HIV (Human Immunodeficiency Virus) infection. The active substance of Retrovir is zidovudine. Retrovir is a medicine belonging to the class of antiretrovirals. It belongs to the category of medicines called nucleoside reverse transcriptase inhibitors (NRTI). Retrovir does not lead to a cure of the HIV infection. It allows for reducing the amount of virus in your body and maintaining it at a low level. Retrovir also increases the number of CD4 cells in your blood. CD4 cells are a type of blood cells (white blood cells) important for helping your body fight infections. Retrovir is used, in association with other medicines (combination of antiretrovirals), to treat HIV in adults and children. In order to control your HIV infection and stop the worsening of your disease, it is important that you take all your medicines. If you are pregnant, your doctor may ask you to take Retrovir with the aim of helping to reduce the risk of HIV transmission to your baby before birth. After birth, Retrovir may be given to your baby to help prevent them from being infected with HIV. HIV infection is transmitted by sexual contact with an already infected person, or by contact with infected blood (for example, by sharing injection needles).
Full clinical reference
Additional sections are available in French. Read the original document; the information concerns the French reference product.
Uses
Retrovir capsule is indicated as part of antiretroviral combinations, for the treatment of adults and children infected with the Human Immunodeficiency Virus (HIV).
Chemoprophylaxis with Retrovir is indicated in pregnant women, HIV positive (after 14 weeks of amenorrhea), in the prevention of mother-to-fetus transmission of HIV and in the primary prophylaxis of HIV infection in the newborn.
Driving
No study has evaluated the effect of Retrovir on driving performance or the ability to use machines. Due to the pharmacology of this medicine, no deleterious effect on such activities is expected. However, the clinical state of the patient and the adverse effects of Retrovir should be kept in mind to define the fitness of patients to drive a vehicle or to use machines.
Hospital price
141,70 MAD
Commercial status
Commercialisé AO
Type
Generic
Therapeutic class
INFECTIOLOGIE-PARASITOLOGIE
References and update dates
AMMPS — catalogue marocain officiel · 2026-10-01
Product and price referenceBase de données publique des médicaments (France) · 2026-09-29 · Licence Ouverte
Read medical referenceThis information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-10-01: 226,00 MAD
Reference price recorded since 2017-12-18: 226,00 MAD
Referenced presentations and strengths
Same ingredient, strength and form
This grouping does not establish interchangeability.
Other strengths and forms
Routes and instructions may differ.
- AVIRO-Z · 300 MG · film-coated tablet · box 60 tablets
- AVIRO-Z · 300 MG · film-coated tablet · box 60 tablets
- AVIRO-Z · 300 MG · film-coated tablet · box of 60
- RETROVIR · 50 MG · oral solution · 1 bottle 200 ml
- RETROVIR · 250 MG · capsule · box of 40
- RETROVIR · 300 MG · tablet · box of 28
- RETROVIR · 300 MG · tablet · box of 60
- RETROVIR · 100 MG / 10 ML · oral solution · bottle de 200 ml
